Skip to main content

We Deliver First-in-Class Therapies

We are an clinical-stage pharmaceutical company creating first-in-class therapies designed to boost expression of therapeutic genes in diseased cells.


Male scientist taking samples at lab bench
Close up of RNA molecule

RNAa Technology:

RNAa (RNA activation) is a platform technology to selectively turn genes on by using short duplex RNA known as small activating RNA (saRNA).

RNAa is among the limited technologies capable of stimulating the production of targeted endogenous genes.


Our Pipeline:
The Push for the Next
Generation of Therapeutics

Ractigen has a diverse pipeline covering previously undruggable diseases and monogenic disorders including oncology, neurological and neuromuscular disorders, and liver-related indications.  

The pipeline explores the boundaries of our technology and pushes for the next generation of RNAa therapeutics.  


Female scientist operating analysis machine

Meet Our Team

Our leadership comprises a unified team of experts in RNA research and drug development, including the pioneers of RNAa technology, specialists in nucleic acid chemistry, biotech entrepreneurs, and authorities in drug discovery.


Male scientist reviewing print out


May 21, 2024 in Homepage News, News Highlight, RAG-01

Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy

SUZHOU, China, May 21, 2024 – Ractigen Therapeutics, a pioneering developer of small activating RNA…
Read More
January 27, 2022 in Company News, Homepage News

Ractigen Therapeutics closes an additional $30 million in Series A+ funding to push development of its RNAa platform

Ractigen Therapeutics today announced the closing of a Series A+ financing round totaling $30 million…
Read More
February 10, 2021 in Company News, Homepage News

Ractigen Therapeutics closes on $17 Million Series A to advance lead program into clinical phase, led by Hillhouse Venture Capital

Ractigen Therapeutics, a leading company in the saRNA drug space, announced that it has closed…
Read More
May 19, 2020 in Company News, Homepage News

CB Insights lists Ractigen as one of the Top RNA biotech companies in China

Today, CB Insights China published, for the first time, a top list of RNA biotech…
Read More